Publications by authors named "Isma Benattia"

Claim this Profile
S
Structured Benefit-Risk Assessment Across the Product Lifecycle: Practical Considerations.
Meredith Y Smith, Isma Benattia, Carmit Strauss, Laura Bloss, Qi Jiang

Ther Innov Regul Sci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.
Meredith Y Smith, Isma Benattia

Drug Saf· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Jonathan Davidson, David S Baldwin, Dan J Stein, Ron Pedersen, Saeed Ahmed, Isma Benattia

Int Clin Psychopharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Charles B Nemeroff, Richard Entsuah, Isma Benattia, Mark Demitrack, Diane M Sloan

Biol Psychiatry· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Jonathan Davidson, David Baldwin, Dan J Stein, Enrique Kuper, Isma Benattia

Arch Gen Psychiatry· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Jonathan Davidson, Barbara O Rothbaum, Phebe Tucker, Gregory Asnis, Isma Benattia

J Clin Psychopharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
Kurt Kroenke, Nicholas Messina, Isma Benattia, Jay Graepel, Jeff Musgnung

J Clin Psychiatry· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Shlomo Brook, Jeorg Walden, Isma Benattia, Cynthia O Siu, Steven J Romano

Psychopharmacology (Berl)· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Donald E N Addington, Christos Pantelis, Mary Dineen, Isma Benattia, Steven J Romano

J Clin Psychiatry· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis